secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0000950170-25-088499
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla sets 2025 bonus targets, elects directors at annual meeting
-------------------------------------------------------------------

- 2025 Bonus Plan approved: CEO target 60% of base, CFO 40%, CMO 40%; payout 50%-125%.
- Corporate goals: clinical milestones 25%, financing 50%, financial/people 20%, brand awareness 5%.
- Annual meeting elected directors Gray, Moran, Steinman; ratified Ernst & Young as auditor (30.2M for).
- Say-on-pay non-binding vote passed with 8.96M for vs 4.49M against; 52% of shares voted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025088499/0000950170-25-088499-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017025088499/bcab-20250617.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-088499

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer